Skip to main navigation Skip to search Skip to main content

The anti-apoptosis effect of MLAA-34 in leukemia and the β-catenin/T cell factor 4 protein pathway

  • Lu Qian
  • , Wanggang Zhang
  • , Pengyu Zhang
  • , Bo Lei
  • , Xiu Wang
  • , Man Wang
  • , Ju Bai
  • , Aili He
  • Xi'an Jiaotong University
  • The Fourth hospital in Xi’an

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Objective This study aims to observe the effects of MLAA-34 gene in leukemia and explore its mechanism. Methods MLAA-34 RNAi vector was constructed. NOD/SCID mice and 293T cells, K562 cells, HL60 cells and U937 cells were used in this study. They were divided into MLAA-34-siRNA group and control group. The proliferation ability and apoptosis of cells were detected. The expression levels of β-Catenin and TCF 4 were determined using western blotting and immunohistochemical methods. Results There was significant correlation between MLAA-34 gene and U937 cell proliferation, the apoptosis rates of U937 cells with siRNA infection were higher than that of control group. There were significant differences in the expression levels of β-Catenin and TCF 4 between U937 cells and U937 with MLAA-34-siRNA cells group. Conclusions MLAA-34 gene had anti-apoptotic effect in leukemia, which maybe through the β-Catenin/TCF 4 pathway.

Original languageEnglish
Pages (from-to)2270-2278
Number of pages9
JournalAmerican Journal of Translational Research
Volume7
Issue number11
StatePublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Apoptosis
  • Leukemia
  • MLAA-34
  • β-Catenin/TCF 4 pathway

Fingerprint

Dive into the research topics of 'The anti-apoptosis effect of MLAA-34 in leukemia and the β-catenin/T cell factor 4 protein pathway'. Together they form a unique fingerprint.

Cite this